| pubmed-article:19011858 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19011858 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:19011858 | lifeskim:mentions | umls-concept:C0278996 | lld:lifeskim |
| pubmed-article:19011858 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:19011858 | lifeskim:mentions | umls-concept:C0032207 | lld:lifeskim |
| pubmed-article:19011858 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:19011858 | lifeskim:mentions | umls-concept:C1441547 | lld:lifeskim |
| pubmed-article:19011858 | lifeskim:mentions | umls-concept:C0210657 | lld:lifeskim |
| pubmed-article:19011858 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:19011858 | lifeskim:mentions | umls-concept:C1521801 | lld:lifeskim |
| pubmed-article:19011858 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19011858 | pubmed:dateCreated | 2009-6-1 | lld:pubmed |
| pubmed-article:19011858 | pubmed:abstractText | This phase I study characterized the pharmacokinetics of free and total platinum derived from cisplatin administered alone and in combination with pemetrexed. Secondary objectives were to assess the pharmacokinetics of pemetrexed when it is combined with cisplatin as well as to evaluate the safety profile and document antitumor activity associated with this combination. | lld:pubmed |
| pubmed-article:19011858 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19011858 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19011858 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19011858 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19011858 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19011858 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19011858 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19011858 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19011858 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19011858 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:19011858 | pubmed:issn | 1432-0843 | lld:pubmed |
| pubmed-article:19011858 | pubmed:author | pubmed-author:VermorkenJan... | lld:pubmed |
| pubmed-article:19011858 | pubmed:author | pubmed-author:CiuleanuTudor... | lld:pubmed |
| pubmed-article:19011858 | pubmed:author | pubmed-author:LatzJane EJE | lld:pubmed |
| pubmed-article:19011858 | pubmed:author | pubmed-author:MusibLuna CLC | lld:pubmed |
| pubmed-article:19011858 | pubmed:author | pubmed-author:SpecenierPol... | lld:pubmed |
| pubmed-article:19011858 | pubmed:author | pubmed-author:DarsteinChris... | lld:pubmed |
| pubmed-article:19011858 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19011858 | pubmed:volume | 64 | lld:pubmed |
| pubmed-article:19011858 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19011858 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19011858 | pubmed:pagination | 233-41 | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:meshHeading | pubmed-meshheading:19011858... | lld:pubmed |
| pubmed-article:19011858 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19011858 | pubmed:articleTitle | Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients. | lld:pubmed |
| pubmed-article:19011858 | pubmed:affiliation | Department of Medical Oncology, Antwerp University Hospital, Wilrijkstraat 10, 2650, Edegem, Belgium. | lld:pubmed |
| pubmed-article:19011858 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19011858 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19011858 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:19011858 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19011858 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19011858 | lld:pubmed |
